<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02698007</url>
  </required_header>
  <id_info>
    <org_study_id>0690-15-RMC</org_study_id>
    <nct_id>NCT02698007</nct_id>
  </id_info>
  <brief_title>Safety and Benefits of Using Laryngeal Mask Airway to Keep Airway Potency During Fiber-optic Bronchoscopy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rabin Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rabin Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bronchoscopy is a method of diagnosis and treatment of common respiratory diseases and lung&#xD;
      recognized for many years.&#xD;
&#xD;
      Since the action takes place in the airways and in light of the use of sedation, when&#xD;
      performing, the procedure requires caution to keep potent airway and breathing sufficient&#xD;
      enough.&#xD;
&#xD;
      Most of the bronchoscopy done without the aid of equipment for advanced airway protection.&#xD;
      During the operation done monitoring hemodynamics: such as blood pressure, pulse and&#xD;
      respiratory such as percutaneous oxygen saturation and carbon dioxide.&#xD;
&#xD;
      Laryngeal Mask Airway (LMA) - is a tool that has been shown to be effective in securing of&#xD;
      airway respiratory activity during positive-pressure ventilation.&#xD;
&#xD;
      Several studies have shown that the use of LMA is a convenient and safe while performing&#xD;
      bronchoscopy for airways and lungs. However, most of the studies were for certain patient&#xD;
      groups such as children, immuno-compromised patients.&#xD;
&#xD;
      Or benefits and safety LMA in front of intubation during bronchoscopy.&#xD;
&#xD;
      Our aim to assess the safety and efficacy LMA in not mechanically ventilated patients&#xD;
      undergoing flexible elective bronchoscopy .&#xD;
&#xD;
      Another objective, to examine whether there is a special group of patients enjoy the LMA more&#xD;
      than others.&#xD;
&#xD;
      Patients will be divided randomly into two groups alternately by order, one patient study&#xD;
      group and the next one to control.&#xD;
&#xD;
      Study group : LMA is inserted under sedation and used during the procedure.&#xD;
&#xD;
      Control group - performing bronchoscopy under sedation without LMA.&#xD;
&#xD;
      About 50 people are needed each group.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pulse oximetry &lt;90%,</measure>
    <time_frame>during bronchoscopy procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percutaneous Carbon Dioxide &gt;55%,</measure>
    <time_frame>during bronchoscopy procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>arrhythmia by ecg monitoring.</measure>
    <time_frame>during bronchoscopy procedure</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Respiratory Disease Undergoing Elective Bronchoscopy.</condition>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>without lma</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard fiberoptic bronchoscopy without lma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>with lma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>fiberoptic bronchoscopy with the use of lma</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laryngeal Mask Airway (LMA)</intervention_name>
    <description>Fiberoptic bronchoscopy with the use of LMA</description>
    <arm_group_label>with lma</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Above 18 y.o&#xD;
&#xD;
          -  Competency to sign informed consent.&#xD;
&#xD;
          -  Room air oxygen saturation above 95%&#xD;
&#xD;
          -  Stable hemodynamically and respiratory during the start procedure.&#xD;
&#xD;
          -  Undergoing elective bronchoscopy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women and special groups will not be included in the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Pulmonary Institute,Rabin Medical Center</name>
      <address>
        <city>Petach Tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <study_first_submitted>February 4, 2016</study_first_submitted>
  <study_first_submitted_qc>February 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2016</study_first_posted>
  <last_update_submitted>October 13, 2016</last_update_submitted>
  <last_update_submitted_qc>October 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

